Tellus Therapeutics Inc.
Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury.
Company Location
8 Davis Drive, Suite 220
Research Triangle Park
NC
277709
Phone
County
Region
Company Details
Company type
Year founded
2018
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)
Products under development
Tellus' lead candidate targets neural stem cells to promote remyelination in babies and adults.